Building a carbon-neutral pharma supply chain
Follow the lead of sustainability trailblazers by maintaining a resilient pharma supply chain during industry development
Add bookmark
As Covid-19 disrupts supply chains and manufacturing operations around the world, there is a further need for supply chains to become more resilient. Supply chain sustainability also forms a key component of corporate social responsibility, with pharmaceutical companies now aware of the operational, financial, regulatory and reputational risks that hang over them if they fail to meet industry standards.
As supply chain leaders navigate a complex network of continuously evolving markets and relationships for them to facilitate actionable change, they require their companies to critically review their operations to understand the performance, risk and sustainability impact of current supply processes.
This report will help you create impactful changes to the supply chain, by showcasing:
- The impact of sustainable operations on productivity and cost
- Learnings from the sustainability efforts of AstraZeneca, GSK and Takeda
- How a supply chain partner can maximize the outcome of sustainability initiatives
- An exclusive case study on how sustainability efforts in an air cargo terminal led to new levels of efficiency and automation
Download your copy now to find out more.
